×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
LHGDN
Control of von Willebrand factor multimer size and implications for disease.
12163004
2002
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
LHGDN
von Willebrand factor: two sides of a coin.
16102036
2005
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
CTD_human
Vascular and thrombogenic effects of pulmonary exposure to Libby amphibole.
22352330
2012
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
LHGDN
Functional property of von Willebrand factor under flowing blood.
11843285
2002
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
LHGDN
In this study we hypothesized that anthrax infection modulates the activity of von Willebrand factor (VWF) and its endogenous regulator ADAMTS13, which play important roles in hemostasis and thrombosis , including interaction of endothelial cells with platelets.
18263586
2008
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.340
Biomarker
phenotype
CTD_human
Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
3875694
1985
×
Entrez Id:
79001
Gene Symbol:
VKORC1
VKORC1
0.300
Biomarker
phenotype
CTD_human
Inhibition of VKORC1 by oral anticoagulants (OACs) is clinically used in therapy and in prevention of thrombosis .
29581108
2018
×
Entrez Id:
7428
Gene Symbol:
VHL
VHL
0.310
Biomarker
phenotype
GENOMICS_ENGLAND
Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension.
21454469
2011
×
Entrez Id:
7428
Gene Symbol:
VHL
VHL
0.310
AlteredExpression
phenotype
LHGDN
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.
14726398
2004
×
Entrez Id:
7408
Gene Symbol:
VASP
VASP
0.020
Biomarker
phenotype
LHGDN
Impaired platelet responsiveness to clopidogrel identified by flow cytometric vasodilator-stimulated phosphoprotein (VASP ) phosphorylation in patients with subacute stent thrombosis .
17938817
2007
×
Entrez Id:
7408
Gene Symbol:
VASP
VASP
0.020
PosttranslationalModification
phenotype
LHGDN
The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis .
18064332
2007
×
Entrez Id:
7301
Gene Symbol:
TYRO3
TYRO3
0.300
Biomarker
phenotype
CTD_human
Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses.
15733062
2005
×
Entrez Id:
81027
Gene Symbol:
TUBB1
TUBB1
0.010
GeneticVariation
phenotype
LHGDN
The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure.
15956286
2005
×
Entrez Id:
8740
Gene Symbol:
TNFSF14
TNFSF14
0.010
Biomarker
phenotype
LHGDN
Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis .
16186421
2005
×
Entrez Id:
7124
Gene Symbol:
TNF
TNF
0.310
Biomarker
phenotype
CTD_human
The study was performed to investigate, in an animal model of arterial thrombosis in vivo, whether diclofenac differentially influences platelet activation and thrombosis in vessels under non-stimulated conditions or during acute systemic inflammation, such as induced by tumor necrosis factor-alpha (TNF-alpha ).
19691487
2009
×
Entrez Id:
7124
Gene Symbol:
TNF
TNF
0.310
GeneticVariation
phenotype
LHGDN
These data suggest that the TNF-alpha -308 A allele is associated with increased PTFE graft thrombosis and failure in hemodialysis patients.
12580317
2003
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.310
Biomarker
phenotype
LHGDN
Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
14987915
2003
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.310
Biomarker
phenotype
CTD_human
Although larger studies are required, this case report suggests that thrombomodulin gene mutations could be an additional genetic risk factor for thrombosis in carriers of the factor V Leiden mutation.
11132655
2000
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.310
Biomarker
phenotype
CTD_human
Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis.
11518727
2001
×
Entrez Id:
7035
Gene Symbol:
TFPI
TFPI
0.020
AlteredExpression
phenotype
LHGDN
Elevated TF and TFPI levels may be related to thrombosis and atherosclerosis in CRF patients on PD.
14610342
2003
×
Entrez Id:
7035
Gene Symbol:
TFPI
TFPI
0.020
AlteredExpression
phenotype
LHGDN
We conclude that thrombosis patients with low levels of free TFPI are at an increased risk of recurrent VTE.
16270631
2005
×
Entrez Id:
6916
Gene Symbol:
TBXAS1
TBXAS1
0.200
Biomarker
phenotype
RGD
The effect of ozagrel sodium on photochemical thrombosis in rat: therapeutic window and combined therapy with heparin sodium.
12384182
2002
×
Entrez Id:
6915
Gene Symbol:
TBXA2R
TBXA2R
0.010
Biomarker
phenotype
LHGDN
Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases.
12796499
2003
×
Entrez Id:
6573
Gene Symbol:
SLC19A1
SLC19A1
0.010
GeneticVariation
phenotype
LHGDN
G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism.
15964598
2005
×
Entrez Id:
23411
Gene Symbol:
SIRT1
SIRT1
0.300
Therapeutic
phenotype
CTD_human
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1 , and KLF4 and decreased tissue factor.
25339356
2015